https://european-biotechnology.net/wp-content/uploads/2024/10/2024-10-22_dr-michael-chen-standing-with-eprotein-discovery-holding-smart-cartridge-2048x1196-1-1030x602-1.jpg6021030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-22 10:43:352024-10-22 13:32:02Nuclera Secures US$75m to Advance Protein Discovery System
https://european-biotechnology.net/wp-content/uploads/2024/10/WHS_Feature_2024_990-1030x686-1.jpg6861030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-18 12:59:082024-10-18 12:59:08WHO: One billion US$ for global health
https://european-biotechnology.net/wp-content/uploads/2024/10/ikerian-1030x584-1.png5841030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-16 13:25:442024-10-16 13:25:44Swiss Ikerian AG partner with Sanoptis Inc to market AI-image analysis
https://european-biotechnology.net/wp-content/uploads/2024/10/Molcure-e1729083269678-1030x578-1.png5781030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-16 12:55:562024-10-16 12:55:56Antibody developer Yumab partners with Japanese AI specialist Molcure
https://european-biotechnology.net/wp-content/uploads/2024/10/Lundbecks-headquarters-in-Valby-e1728977732319-1030x580-1.jpeg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-15 07:36:572024-10-15 07:36:57Lundbeck to take over Longboard Pharma in US$2.6bn transaction
https://european-biotechnology.net/wp-content/uploads/2024/10/PenkidMOA.png326554Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-09 08:57:572024-10-09 08:57:57Sphingotec licenses kidney function test
